๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Acute ataxia, Graves' disease, and stiff person syndrome

โœ Scribed by Su-Ynn Chia; Richard Chua; Yew-Long Lo; Meng-Cheong Wong; Ling-Ling Chan; Eng-King Tan


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
56 KB
Volume
22
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

Stiff person syndrome (SPS) has been associated with autoimmune diseases, such as Type 1 diabetes mellitus and autoimmune thyroid disease (Hashimoto's thyroiditis), among others. The association of SPS with hyperthyroidism is extremely rare. We describe a patient with uncontrolled Graves' disease and undiagnosed SPS, who presented initially with acute ataxia simulating a cerebrovascular accident. Initiation of immunosuppressive therapy dramatically improved the patient's Graves' disease within 2 weeks but the neurological symptoms were not alleviated after a followโ€up period of 3 years. ยฉ 2007 Movement Disorder Society


๐Ÿ“œ SIMILAR VOLUMES


Stiff-person syndrome: An autoimmune dis
โœ Philip Blum; Dr. Joseph Jankovic ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 774 KB

Stiff-person syndrome (SPS) is characterized by progressive, usually symmetric rigidity of the axial muscles with superimposed painful spasms precipitated by tactile stimuli, passive stretch, volitional movement of affected or unaffected muscles, startling noises, and emotional stimuli. Electromyogr

Quality of life in stiff person syndrome
โœ Willibald Gerschlager; Anette Schrag; Peter Brown ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 75 KB

## Abstract Stiff person syndrome (SPS) is a rare, chronic disorder characterized by painful spasm and stiffness. We investigated the quality of life (QoL) in SPS patients, and identified factors associated with impairment in patients' QoL. Twentyโ€four SPS patients (10 men, 14 women; mean age ยฑ S.D

Response to steroid treatment in antiโ€“gl
โœ Ji-Youn Kim; Eun Joo Chung; Jong-Hun Kim; Ki-Young Jung; Won Yong Lee ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 60 KB

Glutamic acid decarboxylase (GAD) is an enzyme that catalyzes the conversion of glutamate to โฅ-aminobutyric acid (GABA). Anti-GAD antibody (GAD-Ab) is considered to be a marker for stiff person syndrome (SPS), 1 insulin-dependent diabetes mellitus (IDDM), and polyendocrine autoimmune syndrome. 2 Add

PET evidence of central GABAergic change
โœ Daniela Perani; Valentina Garibotto; Andrea Panzacchi; Rosa Maria Moresco; Paola ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 80 KB

## Abstract We measured expression of central nervous system GABAโ€A receptors with ^11^Cโ€flumazenil (^11^Cโ€FMZ) and PET in two subjects with stiff person syndrome (SPS). We found reduced ^11^Cโ€FMZ binding potential (BP) in motorโ€premotor cortex, and increased ^11^Cโ€FMZ BP in the cerebellar nuclei.